MAGEA9 antibody (N-Term)
Quick Overview for MAGEA9 antibody (N-Term) (ABIN202005)
Target
See all MAGEA9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Human MAGEA9
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Protein A purified
-
Immunogen
-
Synthetic peptide from N-Terminus of human MAGEA9 (P43362, NP_005356). Percent identity by BLAST analysis: Human, Gorilla, Gibbon (100%), Marmoset (92%), Monkey (85%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: WB (2.5 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- MAGEA9 (Melanoma Antigen Family A, 9 (MAGEA9))
-
Alternative Name
- MAGEA9
-
Background
-
Name/Gene ID: MAGEA9
Synonyms: MAGEA9, Cancer/testis antigen 1.9, CT1.9, MAGE-9 antigen, MAGE9, MAGEA9A, Melanoma-associated antigen 9, Melanoma antigen family A, 9, MAGEA9B -
Gene ID
- 4108
-
NCBI Accession
- NP_005356
-
UniProt
- P43362
Target
-